Home＞ACADEMIA
DPP-4 Inhibitor Prevents Deterioration in Cardiac Diastolic Function in Diabetes Patients: Research Sub-Analysis(May.26.2017)
The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin significantly inhibited deterioration in cardiac diastolic function in diabetes patients, according to results of a clinical research sub-analysis announced by Saga University on May 24 ...
(LOG IN FOR FULL STORY)
-
- Research Group Builds New Pathogenic Variants Database for Japanese Hereditary Breast Cancer Oct.16
-
I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home
Oct.02
-
New Treatment GL for Statin Intolerance Compiled by Atherosclerosis Society, 3 Other Academic Societies
Oct.01
-
Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist
Sep.21
-
Oncologist Hails Tagrisso Approval for 1st-Line Lung Cancer Treatment
Sep.14
- MHLW Proposes New Approval Framework Incorporating Conditional OK, Sakigake Scheme(Oct.19)
- Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand(Oct.19)
- Council Approves MHLW’s Plan to Deal with Difficult-to-Develop Drugs and Indications(Oct.19)
- PMDA to Focus on Proper Use of Sakigake and Conditional Approval Systems in Its 4th Midterm Plan(Oct.19)
- Takeda Earns Japan Clearance for Shire Acquisition(Oct.19)
